BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22225872)

  • 1. The inflammasome puts obesity in the danger zone.
    Stienstra R; Tack CJ; Kanneganti TD; Joosten LA; Netea MG
    Cell Metab; 2012 Jan; 15(1):10-8. PubMed ID: 22225872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.
    Kawaguchi M; Takahashi M; Hata T; Kashima Y; Usui F; Morimoto H; Izawa A; Takahashi Y; Masumoto J; Koyama J; Hongo M; Noda T; Nakayama J; Sagara J; Taniguchi S; Ikeda U
    Circulation; 2011 Feb; 123(6):594-604. PubMed ID: 21282498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of inflammasome activation: recent advances and novel insights.
    Vanaja SK; Rathinam VA; Fitzgerald KA
    Trends Cell Biol; 2015 May; 25(5):308-15. PubMed ID: 25639489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammasomes in kidney disease.
    Anders HJ; Muruve DA
    J Am Soc Nephrol; 2011 Jun; 22(6):1007-18. PubMed ID: 21566058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of inflammasomes in adipose tissue of women with gestational diabetes.
    Lappas M
    Mol Cell Endocrinol; 2014 Jan; 382(1):74-83. PubMed ID: 24055273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure.
    Maslanik T; Mahaffey L; Tannura K; Beninson L; Greenwood BN; Fleshner M
    Brain Behav Immun; 2013 Feb; 28():54-62. PubMed ID: 23103443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications.
    Osawa R; Williams KL; Singh N
    J Infect; 2011 Feb; 62(2):119-29. PubMed ID: 20950647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.
    Feldmeyer L; Keller M; Niklaus G; Hohl D; Werner S; Beer HD
    Curr Biol; 2007 Jul; 17(13):1140-5. PubMed ID: 17600714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, cytokines and insulin resistance: a clinical perspective.
    Wieser V; Moschen AR; Tilg H
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome activation: from inflammatory disease to infection.
    Dunne A
    Biochem Soc Trans; 2011 Apr; 39(2):669-73. PubMed ID: 21428959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 beta targeted therapy for type 2 diabetes.
    Maedler K; Dharmadhikari G; Schumann DM; Størling J
    Expert Opin Biol Ther; 2009 Sep; 9(9):1177-88. PubMed ID: 19604125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion.
    Kopfnagel V; Wittmann M; Werfel T
    Exp Dermatol; 2011 Dec; 20(12):1027-9. PubMed ID: 22092578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response.
    Liu T; Yamaguchi Y; Shirasaki Y; Shikada K; Yamagishi M; Hoshino K; Kaisho T; Takemoto K; Suzuki T; Kuranaga E; Ohara O; Miura M
    Cell Rep; 2014 Aug; 8(4):974-82. PubMed ID: 25127135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
    Satoh T; Otsuka A; Contassot E; French LE
    Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inflammasome].
    Okumura C; Haraikawa K; Suehiro S; Ito Y; Masumoto J
    Nihon Rinsho; 2013 Aug; 71(8):1497-504. PubMed ID: 23967686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome.
    Labbé K; McIntire CR; Doiron K; Leblanc PM; Saleh M
    Immunity; 2011 Dec; 35(6):897-907. PubMed ID: 22195745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signal for the caspase-1 inflammasome free of TLR.
    Dinarello CA
    Immunity; 2007 Apr; 26(4):383-5. PubMed ID: 17459804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SBP2 deficiency in adipose tissue macrophages drives insulin resistance in obesity.
    Wang N; Tan HY; Li S; Wang D; Xu Y; Zhang C; Xia W; Che CM; Feng Y
    Sci Adv; 2019 Aug; 5(8):eaav0198. PubMed ID: 31453320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis.
    Lee HY; Kim J; Quan W; Lee JC; Kim MS; Kim SH; Bae JW; Hur KY; Lee MS
    Autophagy; 2016 Aug; 12(8):1390-403. PubMed ID: 27337687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.
    Dalmas E; Venteclef N; Caer C; Poitou C; Cremer I; Aron-Wisnewsky J; Lacroix-Desmazes S; Bayry J; Kaveri SV; Clément K; André S; Guerre-Millo M
    Diabetes; 2014 Jun; 63(6):1966-77. PubMed ID: 24520123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.